Kinnate Biopharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Kinnate Biopharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q4 2023.
  • Kinnate Biopharma Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 46.6M shares, a 5.7% increase year-over-year.
  • Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 46.6M shares, a 5.7% increase from 2022.
  • Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 44.1M shares, a 1.07% increase from 2021.
  • Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 43.6M shares, a 544% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 46.6M +2.51M +5.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 47.1M +2.94M +6.67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 46.7M +2.65M +6.03% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 45.4M +1.53M +3.48% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 44.1M +465K +1.07% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 44.2M +487K +1.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 44M +467K +1.07% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 43.9M +405K +0.93% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 43.6M +36.8M +544% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 43.7M +39.9M +1065% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 43.5M +39.8M +1075% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 43.5M +39.8M +1084% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 6.77M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 3.75M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 3.71M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 3.67M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.